Other News To Note
• AtheroNova Inc., of Irvine, Calif., completed its pre-investigational new drug application meeting with the FDA for AHRO-001 in the prevention and regression of atherosclerotic plaque.
• Emerald BioStructures, of Bainbridge Island, Wash., reported a three-year extension of its ongoing collaboration with Brussels, Belgium-based UCB SA, started in 2009, which will provide Emerald with research funding over the three-year period and the opportunity to receive milestones and royalties on future drug product revenues.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter